Medikit Co., Ltd.

As of March 31, 2026, Medikit Co., Ltd. carries a market capitalization of 43.30B, placing it among publicly traded companies globally. Its enterprise value stands at 22.37B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Medikit Co., Ltd.'s next confirmed earnings release is scheduled for November 12, 2026.

As of March 31, 2026, Medikit Co., Ltd. has 14.48M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Medikit Co., Ltd. maintains a current ratio of 6.25, meaning it holds 6.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 23, 2026, Medikit Co., Ltd.'s stock has declined approximately 0.81% over the past 52 weeks. The 50-day moving average sits at 2,825.54, while the 200-day moving average is 2,898.28.

As of March 31, 2026, Medikit Co., Ltd. holds 20.95B in cash and equivalents against 18.97M in total debt, resulting in a net debt position of -20.95B. Total book value stands at 46.78B, with working capital of 27.90B providing operational flexibility.

Medikit Co., Ltd.'s most recent stock split took place on March 30, 2020 with a 1:2 split ratio.